Crispr Therapeutics shares owned by Rockefeller Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Rockefeller Capital Management
from 13F filings
Historical chart of Rockefeller Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Rockefeller Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.6M | 149k | 64.81 |
| 2025-06-30 | $5.6M | 115k | 48.64 |
| 2025-03-31 | $3.1M | 91k | 34.03 |
| 2024-12-31 | $3.5M | 90k | 39.36 |
| 2024-09-30 | $4.4M | 93k | 46.98 |
| 2024-06-30 | $5.1M | 94k | 54.01 |
| 2024-03-31 | $5.4M | 79k | 68.16 |
| 2023-12-31 | $5.0M | 80k | 62.60 |
| 2023-09-30 | $3.4M | 75k | 45.39 |
| 2023-06-30 | $4.1M | 74k | 56.14 |
| 2023-03-31 | $3.5M | 77k | 45.22 |
| 2022-12-31 | $3.3M | 81k | 40.65 |
| 2022-09-30 | $5.7M | 95k | 59.70 |
| 2022-06-30 | $874k | 15k | 57.14 |
| 2022-03-31 | $1.5M | 24k | 61.22 |
| 2021-12-31 | $1.8M | 24k | 74.83 |
| 2021-09-30 | $1.9M | 17k | 109.38 |
| 2021-06-30 | $572k | 3.5k | 161.29 |
| 2021-03-31 | $560k | 4.6k | 121.85 |
| 2020-12-31 | $893k | 5.8k | 152.96 |
| 2020-09-30 | $376k | 4.5k | 83.17 |
| 2020-06-30 | $272k | 3.7k | 73.27 |
| 2020-03-31 | $72k | 1.7k | 42.24 |
| 2019-12-31 | $112k | 1.8k | 60.64 |
| 2019-09-30 | $77k | 1.9k | 41.13 |
| 2019-06-30 | $93k | 2.0k | 46.99 |
| 2019-03-31 | $71k | 2.0k | 35.88 |
| 2018-12-31 | $57k | 2.0k | 28.80 |
| 2018-09-30 | $88k | 2.0k | 44.47 |
| 2018-06-30 | $116k | 2.0k | 58.62 |
More positions owned by Rockefeller Capital Management
View all positions for Rockefeller Capital Management